BIOGEN INC. is 3.5x more valuable than BIO-TECHNE Corp by market capitalization ($28.68 B vs $8.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TECH | BIIB |
|---|---|---|
| Market cap | $8.22 B | $28.68 B |
| US-listed rank | #1055 | #476 |
| Revenue (latest FY) | $1.22B | $9.89B |
| Net income (latest FY) | $73.40M | $1.29B |
| Net margin | 6.0% | 13.1% |
| P/E (trailing FY) | 112.0 | 22.2 |
| SEC filings | 1,229 | 2,690 |
BIOGEN INC. is 3.5x more valuable than BIO-TECHNE Corp by market capitalization ($28.68 B vs $8.22 B).
In their latest fiscal years, BIO-TECHNE Corp reported $1.22B in revenue while BIOGEN INC. reported $9.89B.
Full pages: BIO-TECHNE Corp and BIOGEN INC., or browse the full rankings.